Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Frank Breunig"'
Autor:
Sebastian Toncar, Thomas Schmiedeke, Thomas Vogl, Nils Pollak, Michael Leidig, Beatrix Büschges-Seraphin, Marianne Kleinert, Cord Schneuzer, Christina Klaeffling, Clemens Grupp, Christoph Blaser, Susanne Berweck, Rüdiger Götz, Stefan Fischer, Andreas Schmitt, Bettina Wirth, Frank Breunig, Markus Ketteler, Hendrick Witsch, Frank Strutz, Uwe Malzahn, Oliver Jung, Markus Schneider, Julian Gebhardt, Jan Goßmann, Mohamed Marwan, Holger Naujoks, Mara Dörken, L. Schramm, Ewelina Sobkowiak, Michael Heckel, Joanna Harazny, Arnfried Klingbeil, J Zimmermann, Maria Moritz, Heribert Fink, Raoul Zeltner, Patrick Biggar, Rolf Janka, Ahmet Cakmak, Stefan Büttner, Christoph Betz, Fabian Hammer, Heike Schneider, Sarah Rudolf, Beate Schamberger, Imke Reimer, Claudius Kleinert, Michael Brunner, Sabine Schütterle, Susanne Schwedler, Vera Krane, Thorsten Klink, Sophie Richter, Christian Ritter, Markus Schöffauer, Tilo Freiwald, Helmut Geiger, Ulrike Raff, Benjamin-Florian Koch, Renate Hammerstingl, Thomas Bochannek, Joachim Hoyer, Wolfgang Freisinger, Paul Würmell, Daniel Sollinger, Vladimir Vasiljuk, Michael Schmid, Clemens Reichert, Jens Lutz, Stefan Störk, Reinhard Schneider, Andrea Heyd-Schramm, Thomas Döltz, Brigitte Moye, Kai-Olaf Netzer, Kai-Uwe Eckardt, Jurij Ribel, Christoph Wanner, Julian Donhauser, Thorsten Walther, Julia Weinmann-Menke, Judith Kosowski
Publikováno v:
Kidney International. 95:983-991
Mineralocorticoid receptor antagonists have beneficial effects on left ventricular remodeling, cardiac fibrosis, and arrhythmia in heart failure, but efficacy and safety in dialysis patients is less clear. We evaluated the effect of spironolactone on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc8f0e24798b6d023a9deb6f47218d3
https://doi.org/10.1016/j.kint.2018.11.025
https://doi.org/10.1016/j.kint.2018.11.025
Autor:
Andreas D Kistler, Justyna Siwy, Frank Breunig, Praveen Jeevaratnam, Alexander Scherl, William Mullen, David G Warnock, Christoph Wanner, Derralynn A Hughes, Harald Mischak, Rudolf P Wüthrich, Andreas L Serra
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20534 (2011)
Female patients affected by Fabry disease, an X-linked lysosomal storage disorder, exhibit a wide spectrum of symptoms, which renders diagnosis, and treatment decisions challenging. No diagnostic test, other than sequencing of the alpha-galactosidase
Externí odkaz:
https://doaj.org/article/4596ac9f92c4499ea0df20e143c39816
Autor:
Christoph Wanner, Arndt Rolfs, Frank Breunig, Frank Weidemann, Meinrad Beer, Georg Ertl, Markus Niemann, Stefan Störk, Bart Bijnens
Publikováno v:
Circulation: Cardiovascular Genetics. 7:8-16
Background— Currently, no method is available to identify α-galactosidase A (agalA) mutations determining clinically relevant Fabry disease. In our largest European Fabry cohort, we investigated whether a biomarker, specific for the defect, could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fa1848c5423a4182f81c786ffd899df
https://doi.org/10.1161/circgenetics.113.000249
https://doi.org/10.1161/circgenetics.113.000249
Autor:
Meinrad Beer, Sebastian Herrmann, Claudia Sommer, Frank Breunig, Stefan Störk, Christoph Wanner, Georg Ertl, Markus Niemann, Frank Weidemann
Publikováno v:
Journal of Internal Medicine
Objective The long-term effects of enzyme-replacement therapy (ERT) in Fabry disease are unknown. Thus, the aim of this study was to determine whether ERT in patients with advanced Fabry disease affects progression towards ‘hard’ clinical end-poi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c1274bec466e2f36d0e71da4216a1a
https://doi.org/10.1111/joim.12077
https://doi.org/10.1111/joim.12077
Autor:
Claudia Sommer, Frank Breunig, Lan He, Ann-Kathrin Kahn, Dorothee Schönfeld, Max J. Hilz, Nurcan Üçeyler, Karlheinz Reiners
Publikováno v:
Journal of the Peripheral Nervous System. 16:304-314
Fabry disease (FD) is an X-linked lysosomal storage disorder which may lead to impaired peripheral nerve function, mostly affecting small nerve fibers, and to neuropathic pain. Characteristics of the neuropathy associated with FD and the covariates f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828f9fdaa619dbdcd26f6eb1cadc3d11
https://doi.org/10.1111/j.1529-8027.2011.00365.x
https://doi.org/10.1111/j.1529-8027.2011.00365.x
Autor:
Christoph Wanner, Meinrad Beer, Frank Breunig, Markus Niemann, Claudia Sommer, Frank Weidemann
Publikováno v:
European Journal of Clinical Investigation. 42:455-462
Eur J Clin Invest 2012; 42 (4): 455–462 Abstract Background Fabry disease (FD) is a rare X-linked lysosomal storage disorder leading to an accumulation of globotriaosylceramides in the lysosomes of various organs. Design Being X-chromosomal-linked,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62c784941f6b8ad572a161717a7a5a9b
https://doi.org/10.1111/j.1365-2362.2011.02614.x
https://doi.org/10.1111/j.1365-2362.2011.02614.x
Autor:
H Koestler, Meinrad Beer, Frank Weidemann, Wolfram Machann, W Wuest, C. Wanner, Frank Breunig, D Hahn
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 183:1037-1042
PURPOSE According to echocardiography reports, Fabry cardiomyopathy not only affects the left ventricle (LV) but also the right ventricle (RV). Until now no MRI studies about the effect of enzyme replacement therapy (ERT) on the RV are available. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1de8cde5d730064248d2d81011bc413d
https://doi.org/10.1055/s-0031-1281744
https://doi.org/10.1055/s-0031-1281744
Autor:
Christoph Wanner, Kai Hu, Meinrad Beer, Wolfram Voelker, Sebastian Herrmann, Frank Breunig, Jörg Strotmann, Wolfram Machann, Georg Ertl, Markus Niemann, Frank Weidemann
Publikováno v:
JACC: Cardiovascular Imaging. 4:592-601
Objectives We hypothesized that Fabry cardiomyopathy in female patients might differ substantially from that in male patients and sought to prove this hypothesis in a large cohort consisting of 104 patients with Fabry disease. Background Fabry cardio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6920eee1983f039a0d055057a3889d3
https://doi.org/10.1016/j.jcmg.2011.01.020
https://doi.org/10.1016/j.jcmg.2011.01.020
Autor:
Jörg Strotmann, Kai Hu, Wolfram Voelker, Sebastian Herrmann, Stefan Störk, Christoph Wanner, Markus Niemann, Frank Weidemann, Frank Breunig, Dan Liu, Georg Ertl
Publikováno v:
Ultrasound in Medicine & Biology. 37:37-43
Fabry disease is often linked with a prominent papillary muscle. It remains unknown whether this sign could be used as a diagnostic marker to screen for Fabry patients. Standard echo was performed in 101 consecutive patients with concentric left vent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a675870c18e2cd48670ade0583589a8
https://doi.org/10.1016/j.ultrasmedbio.2010.10.017
https://doi.org/10.1016/j.ultrasmedbio.2010.10.017
Autor:
Georg Ertl, Christoph Wanner, Frank Breunig, Wolfram Voelker, Andrea Emmert, Sebastian Herrmann, Meinrad Beer, Kai Hu, Jörg Strotmann, Frank Weidemann, Markus Niemann
Publikováno v:
Heart. 96:1915-1919
Storage of globotriaosylceramides is present in the left and right ventricles of patients with Fabry disease. Improvement of left ventricular morphology and function during enzyme replacement therapy (ERT) has previously been reported.To analyse the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::764922acbec49050e309c26795ba5f4f
https://doi.org/10.1136/hrt.2010.204586
https://doi.org/10.1136/hrt.2010.204586